---
title: "SeaStar Medical Holding Corp reports results for the quarter ended December 31 - Earnings Summary"
description: "SeaStar Medical Holding Corp reported a quarterly adjusted loss of 90 cents per share for the quarter ended December 31, exceeding last year's loss of $5.50. Revenue was $67,000, below the expected $1"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/233522716.md"
published_at: "2025-03-27T21:52:58.000Z"
---

# SeaStar Medical Holding Corp reports results for the quarter ended December 31 - Earnings Summary

> SeaStar Medical Holding Corp reported a quarterly adjusted loss of 90 cents per share for the quarter ended December 31, exceeding last year's loss of $5.50. Revenue was $67,000, below the expected $150,000. The company incurred a total loss of $4.42 million. Despite the losses, shares rose by 25.3% this quarter. Analysts maintain a "buy" rating, with a median 12-month price target of $7.00. No earnings estimate revisions occurred in the last 30 days.

-   SeaStar Medical Holding Corp reported a quarterly adjusted loss of 90 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-5.50. The lone analyst forecast for the quarter was for a loss of 89 cents per share.
    
-   Revenue was $67.00 thousand​; analysts expected $150.00 thousand.
    
-   SeaStar Medical Holding Corp's reported EPS for the quarter was a loss of 90 cents​.
    
-   The company reported a quarterly loss of $4.42 million.
    
-   SeaStar Medical Holding Corp shares had risen by 25.3% this quarter.
    

FORECAST CHANGES

-   The mean earnings estimate of analysts was unchanged in the last three months.​
    
-   In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
    

RECOMMENDATIONS

-   The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
    
-   Wall Street's median 12-month price target for SeaStar Medical Holding Corp is $7.00
    

This summary was machine generated from LSEG data March 27 at 09:52 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Dec. 31 2024

\-0.89

\-0.90

Missed

Sep. 30 2024

\-1.13

\-1.10

Beat

Jun. 30 2024

\-1.41

\-1.03

Beat

Mar. 31 2024

\-3.75

\-4.75

Missed

### Related Stocks

- [ICU.US - SeaStar Medical](https://longbridge.com/en/quote/ICU.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Unitil 公司申請發行最多 5000 萬美元的普通股 | Unitil Corp：UNITIL CORP 提交申請，擬發行高達 5000 萬美元的普通股 - SEC 備案 | [Link](https://longbridge.com/en/news/276391384.md) |
| Dynamix Corp IV 申請 1.75 億美元的首次公開募股（IPO） | Dynamix Corp：空白支票公司 Dynamix Corp IV - 提交 1.75 億美元首次公開募股申請 - SEC 備案 Dynamix Corp - 打算在紐約證券交易所上市，股票代碼為"DYNXU" - SEC 備案 Dyn | [Link](https://longbridge.com/en/news/276180467.md) |
| Plutonian Acquisition Corp II 計劃進行 1 億美元的首次公開募股 | 空白支票公司 Plutonian Acquisition Corp II 計劃進行 1 億美元的首次公開募股 - SEC 文件   Plutonian Acquisition Corp II：A.G.P. 是首次公開募股的承銷商   Plu | [Link](https://longbridge.com/en/news/276180561.md) |
| Mercor.Io 公司通過股權融資籌集了約 3.304 億美元 | Mercor.Io Corp：MERCOR.IO CORP 表示已通過股權融資籌集約 3.304 億美元 - SEC 文件 | [Link](https://longbridge.com/en/news/276256778.md) |
| American Tower Corp 預計每股收益將達到 1.48 美元 - 盈利預覽 | 美國塔公司預計在截至 2025 年 12 月 31 日的期間內每股收益為 1.48 美元，季度收入將增長 5.4%，達到 26.86 億美元。平均分析師評級為 “買入”，其中 17 位分析師推薦 “強烈買入” 或 “買入”，6 位分析師為  | [Link](https://longbridge.com/en/news/276439714.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.